Bone mineral density (BMD) testing of the hip is a remarkably helpful tool to assess the risk of osteoporotic fracture in untreated older men and women. Multiple studies have demonstrated a strong and clinically important relationship between lower hip BMD and higher risk of fracture, and multiple clinical practice guidelines recommend BMD screening using dual-energy x-ray absorptiometry (DXA) for all women older than 65 years, and for postmenopausal women with 1 or more strong risk factors for fracture. Sadly, although in the US more than a 1.5 million DXA examinations are performed annually in women older than 65 years, the proportion of that population that actually receives a screening DXA test remains stubbornly low, ranging from 10% to 35%.1
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Bauer DC. The Importance of Careful Patient Selection in the Use of Follow-up Bone Mineral Density Testing. JAMA Intern Med. 2020;180(9):1240–1241. doi:10.1001/jamainternmed.2020.4818
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: